Colorado BioScience Association (CBSA) announces Derek Cole, President of Investor Relations Advisory Solutions, as the new Chairperson of its Board of Directors. Cole assumes chairperson responsibilities from Steve Orndorff, President & CEO of Ariel Pharmaceuticals. In other recent action, six new members were named to the CBSA Board of Directors.

1.
Colorado BioScience Association Names Derek Cole Board Chair and Appoints Six Industry
Leaders to its Board of Directors at the 2013 Annual All‐Member Meeting
Colorado BioScience Association (CBSA) announces Derek Cole, President of Investor Relations
Advisory Solutions, as the new Chairperson of its Board of Directors. Cole assumes chairperson
responsibilities from Steve Orndorff, President & CEO of Ariel Pharmaceuticals. In other recent
action, six new members were named to the CBSA Board of Directors.
Denver, CO – May 3, 2013 – Derek Cole, President of Investor Relations Advisory Solutions (http://iradvisory.com), was
named Chairperson of the Board of Directors for the Colorado BioScience Association (CBSA) at its 2013 Annual All‐
Member meeting held at the Omni Interlocken Resort in Broomfield, CO, Wednesday. The announcement is made by
April Giles, CBSA President & CEO, who says Cole assumes chairperson responsibilities from Steve Orndorff, Ph.D., CEO
of Ariel Pharmaceuticals, Broomfield (http://arielpharma.com).
Cole is an Investor Relations/Finance/Corporate Communications Executive with 22 years of experience in the capital
markets and corporate planning sectors. He has 16 years of dedicated investor relations, corporate communications and
media relations experience focused on supporting the development of private, small‐ and mid‐cap companies. Further,
he has provided financial communications counsel to C‐level executives and board members, and managed and
contributed to a broad spectrum of financing transactions, including venture capital investments, initial public offerings
(4), secondary offerings and institutional private placements, that combined raised approximately $850 million.
Contributing to the research, planning and execution of five M&A transactions, Cole has established initial investor
relations functions at multiple companies and developed and executed multiple award winning strategic
communications programs. A recognized leader in his profession, Cole was elected 2012 Chairman of the National Board
of Directors of National Investor Relations Institute (NIRI); elected to the NIRI National Board of Directors in 2008; served
as Chairman of the Working Group on Financial Disclosure for NIRI’s Standards of Practice for Investor Relations; and as
Co‐Chairman of the national steering committee for the NIRI BioPharma Roundtable
Joining Cole on the CBSA Board officer team will be newly appointed Vice Chairperson Mark Spiecker, CEO, Sharklet
Technologies (http://www.sharklet.com); Jim Wilson, Board Treasurer, Partner, Ernst & Young (http://www.ey.com);
and Lisa Drake, Board Secretary, Director, Government Affairs, Monsanto (http://www.monsanto.com). In other action,
six new board members were appointed by the CBSA Board of Directors.
CBSA’s board is a prestigious group of industry leaders comprised of representatives of biotechnology, medical device,
diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical
services and products to bioscience companies. Board members commit to a three‐year term to work in partnership
with staff to support the drive and determination of over 600 Colorado bioscience companies that work to improve lives
locally and around the world.
“On behalf of the Board of Directors we would like to thank the retiring seven members for their service and welcome
the six new members,” Giles and Cole stated jointly. In addition, special recognition was given to CBSA’s 10‐year
members in honor of the Association’s 10th
anniversary.
‐More‐

2. Page 2
Newly appointed CBSA board members include:
Brenda Fielding, Executive Vice President, Regulatory and Strategic Development, Clinipace
Scott Larson, Senior Vice President, Legal and General Counsel, Terumo BCT
Brett Lund, Executive Vice President, General Counsel and Secretary, Gevo
Bill Marshall, Ph.D., President, CEO, Co‐Founder and Director, miRagen
Chris Myatt, Ph.D., Co‐Founder and CEO, MBio Diagnostics, Inc.
Bob Reddy, Director of Global Marketing, Medtronic
Reappointments of CBSA board members include:
Derek Cole, President, Investor Relations Advisory Solutions
Betty Iverson, Director of State Government Affairs, Johnson & Johnson
Kevin Smith, President/CEO, CID4
Rick Silva, Tech Transfer Office Senior Director, University of Colorado
Sean Moriarty, Vice President, General Counsel, TOLMAR
Bruce Eaton, President & CEO, i2 Pharmaceuticals, Inc.
2013 Corporate Sponsors include:
Titanium – Boettcher Foundation ‐ www.boettcherfoundation.org
Colorado State University ‐ www.colostate.edu
Fisher Scientific ‐ www.fishersci.com
Fitzsimons Redevelopment Authority ‐ www.fitzscience.com
Johnson & Johnson ‐ www.jnj.com
Platinum – Colorado Office of Economic Development and International Trade ‐ www.advancecolorado.com
University of Colorado ‐ www.colorado.edu
Cooley ‐ www.cooley.com
Dorsey & Whitney ‐ www.dorsey.com
Ernst & Young ‐ www.ey.com
PhRMA ‐ www.phrma.org
Gold – Amgen ‐ www.amgen.com
Merck ‐ www.merck.com
Sheridan Ross ‐ www.sheridanross.com
Snell & Wilmer ‐ www.swlaw.com
Silver – CBIZ ‐ www.cbiz.com
EKS&H ‐ www.eksh.com
Faegre Baker Daniels LLP ‐ www.faegrebd.com
GlaxoSmithKline ‐ www.gsk.com
Polsinelli Shughart ‐ www.polsinelli.com
Terumo BCT ‐ www.terumobct.com
‐More‐

3. Page 3
Bronze – DaVita Clinical Research ‐ www.davitaclinicalresearch.com
Genentech ‐ www.gene.com
Pfizer ‐ www.pfizer.com
SomaLogic ‐ www.somalogic.com
TOLMAR ‐ tolmar.com
The Wright Group/Travelers ‐ www.twgservices.com / www.travelers.com
About Colorado BioScience Association
Celebrating ten years of supporting the Bioscience Industry in Colorado in 2013, the CBSA is a not‐for‐profit organization
providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to
promote the growth of the industry by advocating for a better business environment, growing the state's biotech
workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on
behalf of the industry. For more information, visit http://www.cobioscience.com.
CBSA also is found on these social media sites:
Twitter: http://www.twitter.com/COBioscience
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
News Feed: http://coloradobio.blogspot.com
YouTube Channel: http://www.youtube.com/COBioscience
Pinterest: http://pinterest.com/COBioscience
Tumblr: http://cobioscience.tumblr.com
Contacts:
Mae Desaire, Director of Marketing, Colorado BioScience Association ‐ http://www.cobioscience.com –
720‐382‐5918, mdesaire@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations ‐ http://www.absolutelypr.com ‐ 303‐984‐9801,
maggie@absolutelypr.com